Genomic and Proteomic Pathway Mapping Reveals Signatures of Mesenchymal-Epithelial Plasticity in Inflammatory Breast Cancer (original) (raw)
Epithelial-Mesenchymal Transition In Breast Cancer Relates to the Basal-Like Phenotype
jose palacios
Cancer research, 2008
View PDFchevron_right
Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype
john mclachlan
Breast Cancer Research, 2008
View PDFchevron_right
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Pilar Eroles
Cancer Treatment Reviews, 2012
View PDFchevron_right
Exploring breast carcinogenesis through integrative genomics and epigenomics analyses
Norfilza Mokhtar
International Journal of Oncology, 2014
View PDFchevron_right
Integrative, In Silico and Comparative Analysis of Breast Cancer Secretome Highlights Invasive-Ductal-Carcinoma-Grade Progression Biomarkers
Yazan Masannat
Cancers, 2022
View PDFchevron_right
KLF17 is a negative regulator of epithelial–mesenchymal transition and metastasis in breast cancer
Andres Klein-Szanto
Nature Cell Biology, 2009
View PDFchevron_right
Tumor Microenvironmental Signaling Elicits Epithelial-Mesenchymal Plasticity through Cooperation with Transforming Genetic Events
Damian Junk
Neoplasia, 2013
View PDFchevron_right
Data from Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer
Luc Dirix
2023
View PDFchevron_right
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Santiago Ramón y Cajal
Cell Reports, 2019
View PDFchevron_right
Pathways connecting inflammation and cancer
Cecilia Garlanda
Current Opinion in Genetics & Development, 2008
View PDFchevron_right
Gene expression profile in breast cancer comprising predictive markers for metastatic risk
Rachana Santiyanont
Genetics and Molecular Research, 2015
View PDFchevron_right
Inflammatory breast cancer: New factors contribute to disease etiology: A review
Mona Mohamed
Journal of Advanced Research, 2014
View PDFchevron_right
Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer
Pilar Eroles
Molecular Cancer Therapeutics, 2014
View PDFchevron_right
Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival
Shara Reihani
International Journal of Hyperthermia, 2015
View PDFchevron_right
Clinical and molecular aspects of breast cancer: Targets and therapies
Glauber Leitao
Biomedicine & Pharmacotherapy, 2018
View PDFchevron_right
Gene expression in metastatic breast cancer – patterns with prognostic potential in primary tumors and metastatic tissue
Julia Tutzauer
Research Square (Research Square), 2023
View PDFchevron_right
A bioinformatics approach to decode core genes and molecular pathways shared by breast cancer and endometrial cancer
Foyzur Rahman
Informatics in Medicine Unlocked, 2019
View PDFchevron_right
The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
Uwe Roblick
International Journal of Cancer, 2009
View PDFchevron_right
My pathway to understanding the role of the tumour microenvironment in cancer progression
Carmela Ricciardelli
Endocrine-Related Cancer, 2016
View PDFchevron_right
Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer
Graham Colditz
Cancer Research, 2012
View PDFchevron_right
High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer
Ingrid Hedenfalk
Breast Cancer Research, 2006
View PDFchevron_right
Computational Approach to Identify Regulatory Biomarkers in the Pathogenesis of Breast Carcinoma
Dr. HARISHCHANDER ANANDARAM
International Journal of Advanced Computer Science and Applications
View PDFchevron_right
Proteogenomic Analysis of Protein Sequence Alterations in Breast Cancer Cells
Iulia M Lazar
Scientific Reports, 2019
View PDFchevron_right
Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regulated secretion during breast cancer progression
Betül Kutay
Breast Cancer Research, 2014
View PDFchevron_right
Prospective dual role of mesenchymal stem cells in breast tumor microenvironment
Asim Abdel-Mageed
Breast Cancer Research and Treatment, 2013
View PDFchevron_right
Association of angiogenesis and inflammation‑related gene functional polymorphisms with early‑stage breast cancer prognosis
Erika Korobeinikova
Oncology Letters, 2020
View PDFchevron_right
Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition
Katie Lin
PLOS Computational Biology, 2018
View PDFchevron_right
Article Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer
Thư Nguyễn
2015
View PDFchevron_right
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Asish Pati
Journal of Cellular Physiology, 2007
View PDFchevron_right
Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer
Ruby Huang
Current Drug Targets, 2012
View PDFchevron_right
New concepts in breast cancer genomics and genetics
Rodrigo Goncalves
Breast Cancer Research, 2014
View PDFchevron_right
“Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
Carsten Rose
European Journal of Cancer, 2004
View PDFchevron_right
Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized
James Garbe
2007
View PDFchevron_right
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Sendurai A Mani
Proceedings of the …, 2010
View PDFchevron_right
Stromal Oncostatin M cytokine promotes breast cancer progression by reprogramming the tumour microenvironment
Maria Caffarel
Journal of Clinical Investigation, 2022
View PDFchevron_right